Neutrophil-Lymphocyte Ratio in Cardiovascular Disease Risk Assessment
Autor(a) principal: | |
---|---|
Data de Publicação: | 2018 |
Outros Autores: | |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | International Journal of Cardiovascular Sciences (Online) |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-56472018000500532 |
Resumo: | Abstract The development of cardiovascular diseases with atherosclerotic origin is associated with a severe inflammatory process. Neutrophils and lymphocytes are cells sensitive to this type of disorder and their ratio, known as the NLR (neutrophil/lymphocyte ratio), has shown to be useful in clinical practice. The aim of this study was to assess the role of NLR in cardiovascular disease risk assessment. We carried out a literature review in the PubMed databases searching for articles published between 2001 to 2017 and found that NLR is in fact a useful marker for cardiovascular disease. Using NLR in patients at cardiovascular risk would be useful to delineate the prognosis of patients with this disease pattern. |
id |
SBC-2_4ffa357ef0d77f9e1f901dff193f91ff |
---|---|
oai_identifier_str |
oai:scielo:S2359-56472018000500532 |
network_acronym_str |
SBC-2 |
network_name_str |
International Journal of Cardiovascular Sciences (Online) |
repository_id_str |
|
spelling |
Neutrophil-Lymphocyte Ratio in Cardiovascular Disease Risk AssessmentCardiovascular Diseases / physiopathologyBiomarkersNeutrophilsLeukocyte CountAtherosclerosis / physiopathologyInflammationAbstract The development of cardiovascular diseases with atherosclerotic origin is associated with a severe inflammatory process. Neutrophils and lymphocytes are cells sensitive to this type of disorder and their ratio, known as the NLR (neutrophil/lymphocyte ratio), has shown to be useful in clinical practice. The aim of this study was to assess the role of NLR in cardiovascular disease risk assessment. We carried out a literature review in the PubMed databases searching for articles published between 2001 to 2017 and found that NLR is in fact a useful marker for cardiovascular disease. Using NLR in patients at cardiovascular risk would be useful to delineate the prognosis of patients with this disease pattern.Sociedade Brasileira de Cardiologia2018-10-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-56472018000500532International Journal of Cardiovascular Sciences v.31 n.5 2018reponame:International Journal of Cardiovascular Sciences (Online)instname:Sociedade Brasileira de Cardiologia (SBC)instacron:SBC10.5935/2359-4802.20180038info:eu-repo/semantics/openAccessSantos,Heitor OliveiraIzidoro,Luiz Fernando Moreiraeng2018-12-12T00:00:00Zoai:scielo:S2359-56472018000500532Revistahttp://publicacoes.cardiol.br/portal/ijcshttps://old.scielo.br/oai/scielo-oai.phptailanerodrigues@cardiol.br||revistaijcs@cardiol.br2359-56472359-4802opendoar:2018-12-12T00:00International Journal of Cardiovascular Sciences (Online) - Sociedade Brasileira de Cardiologia (SBC)false |
dc.title.none.fl_str_mv |
Neutrophil-Lymphocyte Ratio in Cardiovascular Disease Risk Assessment |
title |
Neutrophil-Lymphocyte Ratio in Cardiovascular Disease Risk Assessment |
spellingShingle |
Neutrophil-Lymphocyte Ratio in Cardiovascular Disease Risk Assessment Santos,Heitor Oliveira Cardiovascular Diseases / physiopathology Biomarkers Neutrophils Leukocyte Count Atherosclerosis / physiopathology Inflammation |
title_short |
Neutrophil-Lymphocyte Ratio in Cardiovascular Disease Risk Assessment |
title_full |
Neutrophil-Lymphocyte Ratio in Cardiovascular Disease Risk Assessment |
title_fullStr |
Neutrophil-Lymphocyte Ratio in Cardiovascular Disease Risk Assessment |
title_full_unstemmed |
Neutrophil-Lymphocyte Ratio in Cardiovascular Disease Risk Assessment |
title_sort |
Neutrophil-Lymphocyte Ratio in Cardiovascular Disease Risk Assessment |
author |
Santos,Heitor Oliveira |
author_facet |
Santos,Heitor Oliveira Izidoro,Luiz Fernando Moreira |
author_role |
author |
author2 |
Izidoro,Luiz Fernando Moreira |
author2_role |
author |
dc.contributor.author.fl_str_mv |
Santos,Heitor Oliveira Izidoro,Luiz Fernando Moreira |
dc.subject.por.fl_str_mv |
Cardiovascular Diseases / physiopathology Biomarkers Neutrophils Leukocyte Count Atherosclerosis / physiopathology Inflammation |
topic |
Cardiovascular Diseases / physiopathology Biomarkers Neutrophils Leukocyte Count Atherosclerosis / physiopathology Inflammation |
description |
Abstract The development of cardiovascular diseases with atherosclerotic origin is associated with a severe inflammatory process. Neutrophils and lymphocytes are cells sensitive to this type of disorder and their ratio, known as the NLR (neutrophil/lymphocyte ratio), has shown to be useful in clinical practice. The aim of this study was to assess the role of NLR in cardiovascular disease risk assessment. We carried out a literature review in the PubMed databases searching for articles published between 2001 to 2017 and found that NLR is in fact a useful marker for cardiovascular disease. Using NLR in patients at cardiovascular risk would be useful to delineate the prognosis of patients with this disease pattern. |
publishDate |
2018 |
dc.date.none.fl_str_mv |
2018-10-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-56472018000500532 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S2359-56472018000500532 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.5935/2359-4802.20180038 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Sociedade Brasileira de Cardiologia |
publisher.none.fl_str_mv |
Sociedade Brasileira de Cardiologia |
dc.source.none.fl_str_mv |
International Journal of Cardiovascular Sciences v.31 n.5 2018 reponame:International Journal of Cardiovascular Sciences (Online) instname:Sociedade Brasileira de Cardiologia (SBC) instacron:SBC |
instname_str |
Sociedade Brasileira de Cardiologia (SBC) |
instacron_str |
SBC |
institution |
SBC |
reponame_str |
International Journal of Cardiovascular Sciences (Online) |
collection |
International Journal of Cardiovascular Sciences (Online) |
repository.name.fl_str_mv |
International Journal of Cardiovascular Sciences (Online) - Sociedade Brasileira de Cardiologia (SBC) |
repository.mail.fl_str_mv |
tailanerodrigues@cardiol.br||revistaijcs@cardiol.br |
_version_ |
1754732625292951552 |